Analysis of second-generation antidepressant drug, sertraline and its active metabolite, N-desmethyl sertraline in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 3, 2009, Pages 221-229

  Patel, Bhavin N ^a,b   Sharma, Naveen ^b   Sanyal, Mallika ^c   Shrivastav, Pranav S ^a  

^a GUJARAT UNIVERSITY   (India)

^b BA Research India Limited   (India)

^c ST XAVIER S COLLEGE   (India)

Author keywords

Human plasma; LC MS MS; Multiple reaction monitoring; N Desmethyl sertraline; Sertraline

Indexed keywords

HUMAN PLASMA; LC-MS/MS; MULTIPLE REACTION MONITORING; N-DESMETHYL SERTRALINE; SERTRALINE;

BINARY MIXTURES; BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; CORRELATION METHODS; CUSTOMER SATISFACTION; ETHERS; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MASS SPECTROMETRY; METABOLITES; PLASMA (HUMAN); PLASMA STABILITY; PLASMAS; QUALITY ASSURANCE; QUALITY CONTROL; QUALITY FUNCTION DEPLOYMENT; SOLVENT EXTRACTION; SPECTROMETERS; SPECTROMETRY; SPECTRUM ANALYSIS; THEOREM PROVING; TOTAL QUALITY MANAGEMENT;

LIQUID CHROMATOGRAPHY;

FLUOXETINE; N DESMETHYL SERTRALINE; SERTRALINE; TERT BUTYL METHYL ETHER; UNCLASSIFIED DRUG;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DILUTION; DRUG BLOOD LEVEL; EXTRACTION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STANDARD; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION STUDY;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; FLUOXETINE; HUMANS; LINEAR MODELS; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERTRALINE; TANDEM MASS SPECTROMETRY;

EID: 58149197503     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.12.008     Document Type: Article

References (39)

1. Sampson S.M. Mayo Clin. Proc. 76 (2001) 739
2. Murdoch D., and McTavish D. Drugs 44 (1992) 604
3. MacQueen G., Born L., and Steiner M. CNS Drug Rev. 7 (2001) 1
4. Comer A.M., and Figgitt D.P. CNS Drugs 14 (2000) 391
5. McClintock S.M., Queenan K., Faniran O., Ranginwala N., and Husain M.M. Aging Health 2 (2006) 199
6. Rudorfer M.V., and Potter W.Z. CNS Drugs 7 (1997) 273
7. Kim K.M., Jung B.H., Choi M.H., Woo J.S., Paeng K.J., and Chung B.C. J. Chromatogr. B 769 (2002) 333
8. Chen X., Duan X., Dai X., and Zhong D. Rapid Commun. Mass Spectrom. 20 (2006) 2483
9. He L., Feng F., and Wu J. J. Chromatogr. Sci. 43 (2005) 532
10. Jain D.S., Sanyal M., Subbaiah G., Pande U.C., and Shrivastav P.S. J. Chromatogr. B 829 (2005) 69
11. Schaller D., Hilder E.F., and Haddad P.R. Anal. Chim. Acta 556 (2006) 104
12. Wille S.M.R., Hee P.V., Neels H.M., Peteghem C.H.V., and Lambert W.E. J. Chromatogr. A 1176 (2007) 236
13. Pujadas M., Pichini S., Civit E., Santamarina E., Perez K., and de la Torre R. J. Pharm. Biomed. Anal. 44 (2007) 594
14. Wille S.M.R., Maudens K.E., Peteghem C.H.V., and Lambert W.E.E. J. Chromatogr. A 1098 (2005) 19
15. Lamas J.P., Salgado-Petinal C., Garcia-Jares C., Llompart M., Cela R., and Gomez M. J. Chromatogr. A 1046 (2004) 241
16. Eap C.B., Bouchoux G., Amey M., Cochard N., Savary L., and Baumann P. J. Chromatogr. Sci. 36 (1998) 365
17. Lucca A., Gentilini G., Lopez-Silva S., and Soldarini A. Ther. Drug Monit. 22 (2000) 271
18. Titier K., Castaing N., Scotto-Gomes E., Pehourcq F., Moore N., and Molimard M. Ther. Drug Monit. 25 (2003) 581
19. Duverneuil C., de la Grandmaison G.L., de Mazancourt P., and Alvarev J.C. Ther. Drug Monit. 25 (2003) 565
20. Silva B.J.G., Lancas F.M., and Queiroz M.E.C. J. Chromatogr. B 862 (2008) 181
21. Chaves A.R., Silva S.M., Queiroz R.H.C., Lancas F.M., and Queiroz M.E.C. J. Chromatogr. B 850 (2007) 295
22. Malfara W.R., Bertucci C., Queiroz M.E.C., Carvalho S.A.D., Bianchi M.L.P., Cesarino E.J., Crippa J.A., and Queiroz R.H.C. J. Pharm. Biomed. Anal. 44 (2007) 955
23. Esrafili A., Yamini Y., and Shariati S. Anal. Chim. Acta 604 (2007) 127
24. Frahnert C., Rao M.L., and Grasmader K. J. Chromatogr. B 794 (2003) 35
25. Tournel G., Houdret N., Hedouin V., Deveaux M., Gosset D., and Lhermitte M. J. Chromatogr. B 761 (2001) 147
26. Silva B.J.G., Queiroz R.H.C., and Queiroz M.E.C. J. Anal. Toxicol. 31 (2007) 313
27. Vasskog T., Anderssen T., Bjergaard S.P., Kallenborn R., and Jensen E. J. Chromatogr. A 1185 (2008) 194
28. Doherty B., Rodriguez V., Leslie J.C., McClean S., and Smyth W.F. Rapid Commun. Mass Spectrom. 21 (2007) 2031
29. Kirchherr H., and Kuhn-Velten W.N. J. Chromatogr. B 843 (2006) 100
30. Sauvage F.L., Gaulier J.M., Lachatre G., and Marquet P. Ther. Drug Monit. 28 (2006) 123
31. Wiener H.L., Kramer H.K., and Reith M.E.A. J. Chromatogr. B 527 (1990) 467
32. Rogowsky D., Marr M., Long G., and Moore C. J. Chromatogr. B 655 (1994) 138
33. Vatassery G.T., Holden L.A., Hazel D.K., and Dysken M.W. Clin. Biochem. 30 (1997) 565
34. Mandrioli R., Saracino M.A., Ferrari S., Berardi D., Kenndler E., and Raggi M.A. J. Chromatogr. B 836 (2006) 116
35. Musenga A., Kenndler E., Mercolini L., Amore M., Fanali S., and Raggi M.A. Electrophoresis 28 (2007) 1823
36. Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May 2001.
37. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 75 (2003) 3019
38. Guidance for Industry: ICH E6 Good Clinical Practice, U.S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), April 1996.
39. Rocci Jr. M.L., Devanarayan V., Haughey D.B., and Jardieu P. AAPS J. 9 (2007) E336